After Kasperkiewicz and Tukaj commenting on “Bullous pemphigoid associated with COVID-19 vaccines: an Italian multicentre study”, the relationship between COVID-19 vaccination and bullous pemphigoid (BP) onset is reconsidered. Moreover mechanisms other than molecular mimicry that could trigger AIBD onset following COVID-19 vaccination and real world clinical data linking the two phenomena are discussed.
Response: Commentary: Bullous pemphigoid associated with COVID-19 vaccines: An Italian multicenter study / Pira A.; Moltrasio C.; Abeni D.; Corra A.; Marzano A.V.; Caproni M.; Di Zenzo G.. - In: FRONTIERS IN MEDICINE. - ISSN 2296-858X. - ELETTRONICO. - 10:(2023), pp. 0-0. [10.3389/fmed.2023.1160672]
Response: Commentary: Bullous pemphigoid associated with COVID-19 vaccines: An Italian multicenter study
Caproni M.;
2023
Abstract
After Kasperkiewicz and Tukaj commenting on “Bullous pemphigoid associated with COVID-19 vaccines: an Italian multicentre study”, the relationship between COVID-19 vaccination and bullous pemphigoid (BP) onset is reconsidered. Moreover mechanisms other than molecular mimicry that could trigger AIBD onset following COVID-19 vaccination and real world clinical data linking the two phenomena are discussed.File | Dimensione | Formato | |
---|---|---|---|
Response- Commentary- Bullous pemphigoid associated with COVID-19 vaccines- An Italian multicenter study.pdf
accesso aperto
Tipologia:
Pdf editoriale (Version of record)
Licenza:
Creative commons
Dimensione
113.44 kB
Formato
Adobe PDF
|
113.44 kB | Adobe PDF |
I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.